CIK 0001626644
- Non-accelerated filer
- Smaller reporting company
Odyssey Health, Inc.
Sign in to watch- Ticker
- ODYY
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jul 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 471022125
- Phone
- +1 702-780-6559
- Business address
- 2300 WEST SAHARA AVENUE, SUITE 800-#4012, LAS VEGAS, NV, 89102
- Former names
- Odyssey Group International, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-28 | FARRELL CHRISTINE Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +500,000 | $0.10 | $50K | 500,000 |
| 2023-12-29 | FARRELL CHRISTINE Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +500,000 | $0.10 | $50K | 500,000 |
| 2023-01-12 | FARRELL CHRISTINE CFO | Grant or award · Restricted Stock Unit (Right to Buy) | +100,000 | $0.30 | $30K | 1,300,000 |
| 2023-01-12 | FARRELL CHRISTINE CFO | Grant or award · Restricted Stock Unit (Right to Buy) | +400,000 | $0.30 | $120K | 1,700,000 |
| 2022-10-14 | FARRELL CHRISTINE Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +500,000 | $0.32 | $159K | 1,100,000 |
| 2022-05-19 | FARRELL CHRISTINE Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | $0.30 | $90K | 1,300,000 |
| 2022-05-19 | FARRELL CHRISTINE Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | $0.30 | $90K | 1,600,000 |
| 2021-01-01 | FARRELL CHRISTINE Chief Financial Officer | Grant or award · Restricted Stock Unit (Right to Buy) | +1,000,000 | $0.18 | $180K | 1,000,000 |
Page 1 of 1 · 8 trades